These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25048571)

  • 1. Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.
    Balenga NA; Martínez-Pinilla E; Kargl J; Schröder R; Peinhaupt M; Platzer W; Bálint Z; Zamarbide M; Dopeso-Reyes IG; Ricobaraza A; Pérez-Ortiz JM; Kostenis E; Waldhoer M; Heinemann A; Franco R
    Br J Pharmacol; 2014 Dec; 171(23):5387-406. PubMed ID: 25048571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB
    Glenn NAK; Finlay DB; Carruthers ER; Mountjoy KG; Walker CS; Grimsey NL
    Br J Pharmacol; 2024 Jul; 181(14):2212-2231. PubMed ID: 37085333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
    Kargl J; Balenga N; Parzmair GP; Brown AJ; Heinemann A; Waldhoer M
    J Biol Chem; 2012 Dec; 287(53):44234-48. PubMed ID: 23161546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum.
    Martínez-Pinilla E; Reyes-Resina I; Oñatibia-Astibia A; Zamarbide M; Ricobaraza A; Navarro G; Moreno E; Dopeso-Reyes IG; Sierra S; Rico AJ; Roda E; Lanciego JL; Franco R
    Exp Neurol; 2014 Nov; 261():44-52. PubMed ID: 24967683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
    Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
    J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
    Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
    J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of GPR55 and either cannabinoid CB
    Martínez-Pinilla E; Rico AJ; Rivas-Santisteban R; Lillo J; Roda E; Navarro G; Lanciego JL; Franco R
    Brain Struct Funct; 2020 Sep; 225(7):2153-2164. PubMed ID: 32691218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPR55 ligands promote receptor coupling to multiple signalling pathways.
    Henstridge CM; Balenga NA; Schröder R; Kargl JK; Platzer W; Martini L; Arthur S; Penman J; Whistler JL; Kostenis E; Waldhoer M; Irving AJ
    Br J Pharmacol; 2010 Jun; 160(3):604-14. PubMed ID: 20136841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Gene and Protein Expression of Cannabinoid CB
    García-Gutiérrez MS; Navarrete F; Navarro G; Reyes-Resina I; Franco R; Lanciego JL; Giner S; Manzanares J
    Neurotherapeutics; 2018 Jul; 15(3):796-806. PubMed ID: 29435814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors.
    Anavi-Goffer S; Irving AJ; Ross RA
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):303-10. PubMed ID: 27089417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.
    Moreno E; Andradas C; Medrano M; Caffarel MM; Pérez-Gómez E; Blasco-Benito S; Gómez-Cañas M; Pazos MR; Irving AJ; Lluís C; Canela EI; Fernández-Ruiz J; Guzmán M; McCormick PJ; Sánchez C
    J Biol Chem; 2014 Aug; 289(32):21960-72. PubMed ID: 24942731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and functional interaction between GPR18 and cannabinoid CB
    Reyes-Resina I; Navarro G; Aguinaga D; Canela EI; Schoeder CT; Załuski M; Kieć-Kononowicz K; Saura CA; Müller CE; Franco R
    Biochem Pharmacol; 2018 Nov; 157():169-179. PubMed ID: 29870711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors.
    Ferrada C; Moreno E; Casadó V; Bongers G; Cortés A; Mallol J; Canela EI; Leurs R; Ferré S; Lluís C; Franco R
    Br J Pharmacol; 2009 May; 157(1):64-75. PubMed ID: 19413572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.
    Balenga NA; Aflaki E; Kargl J; Platzer W; Schröder R; Blättermann S; Kostenis E; Brown AJ; Heinemann A; Waldhoer M
    Cell Res; 2011 Oct; 21(10):1452-69. PubMed ID: 21467997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
    Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
    J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55.
    Kargl J; Balenga NA; Platzer W; Martini L; Whistler JL; Waldhoer M
    Br J Pharmacol; 2012 Apr; 165(8):2611-9. PubMed ID: 21718301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
    Yang H; Zhou J; Lehmann C
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid CB
    Olianas MC; Dedoni S; Onali P
    Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB
    Cruz SL; Sánchez-Miranda E; Castillo-Arellano JI; Cervantes-Villagrana RD; Ibarra-Sánchez A; González-Espinosa C
    Int Immunopharmacol; 2018 Nov; 64():298-307. PubMed ID: 30243065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.